Campaign raises awareness of medicines safety in children and pregnancy

Technology / 19 November 2018

Med Safety Week 2018

Uppsala Monitoring Centre has launched the third annual social media campaign to promote the importance of reporting suspected side effects from medicines.


Taking place from 19-23 November, the campaign forms part of an awareness week involving 32 medicines regulators in the EU, Latin America, Australasia and the Middle East. Regulators will jointly focus on raising reporting numbers for suspected side effects in infants and children, and during pregnancy, including when breastfeeding.

Regulators rely on the reporting of suspected side effects – also known as adverse drug reactions – to make sure medicines on the market are acceptably safe. Unfortunately, all reporting systems suffer from under reporting – this is why the campaign is important to both raise awareness and help strengthen the system. The 2017 campaign reached 2,3 million people on social media, and resulted in an increase of 11% in reporting of adverse drug reactions.

The campaign is being taken forward through the Heads of Medicines Agencies Working Group for Communications Professionals and the International Coalition of Medicines Regulatory Authorities. A number of other organisations – including the European Medicines Agency, the European Commission and patient organisations such as EURORDIS – have also pledged their support. This year, the United Nations’ Universal Children’s Day falls within the awareness week, and both campaigns seek to promote international togetherness and improve children's welfare.

 

Campaign materials include a light-hearted and amusing series of animations produced by UMC, featuring funny cartoon characters whose unfortunate misuse of medicines leads to comical calamities. The short animations have been adapted for use in the 32 countries. Each country-specific version features text in the local language, the logo of the medicine regulatory authority and a link to the national reporting system.

Connect to us!

Besides making the animations available to the countries, UMC will also run the campaign on its social media channels. Connect to us with the hashtag #MedSafetyWeek, or follow us on social media:

• Twitter: @UMCGlobalSafety

• Facebook: @UppsalaMonitoringCentre

• LinkedIn: /Uppsala-Monitoring-Centre


You can also follow any of the 32 participating medicines agencies:

Australia: @TGAgovau

Belgium: @FAGG_be (Dutch); @AFMPS_BE (French)

Bulgaria: www.bda.bg

Colombia: @invimacolombia

Croatia: www.halmed.hr

Czech Republic: @SUKLcz

Denmark: @LMSTdk (Danish);@DKMA_dk (English)

Ecuador: @Arcsa_Ec

El Salvador: @MedicamentosSV

Estonia: @ravimiamet

Finland: @Fimea

France: @ansm

Germany: @bfarm_de

Greece: www.eof.gr

Hungary: @ogyei.gov.hu

Iceland: @lyfjastofnun

Iraq: @MOH.GOV.IQ

Ireland: @TheHPRA

Italy: @Aifa_ufficiale

Jordan: @Jordan_FDA

Latvia: @ZVALatvija

Lithuania: @vvkt.lt

Malta: @medicinesmalta

Mexico: @COFEPRIS

New Zealand: @minhealthnz

Poland: @URPLWMiPB

Portugal: @INFARMED_IP

Romania: @anmdm.ro

Slovak Republic: @sukl_sr

Slovenia: @AgencijaJAZMP

Sweden: @LV_MPA

United Kingdom: @MHRAgovuk

Federica Santoro
Communications Officer, UMC

You may also like


How do we ensure trust in AI/ML when used in pharmacovigilance?

Ensuring trust in AI is paramount to fully reap the benefits of the technology in pharmacovigilance. Yet, how do we do so while grappling with its ever-growing complexity?

26 February 2024

Pregnancy-related pharmacovigilance – New podcast episode

Discover how researchers are addressing crucial challenges in pregnancy-related pharmacovigilance to better protect both mothers and their unborn children.

03 April 2025

Ensuring trust in AI/ML when used in pharmacovigilance – New podcast episode

Ensuring trust in AI is vital to fully reap the benefits of the technology in pharmacovigilance. Yet, how do we do so while grappling with its ever-growing complexity?

27 June 2024